SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-164670
Filing Date
2021-05-18
Accepted
2021-05-18 08:30:34
Documents
14
Period of Report
2021-05-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d168523d8k.htm   iXBRL 8-K 32099
2 EX-99.1 d168523dex991.htm EX-99.1 12229
6 GRAPHIC g168523g74h19.jpg GRAPHIC 5131
  Complete submission text file 0001193125-21-164670.txt   186665

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20210517.xsd EX-101.SCH 3087
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20210517_lab.xml EX-101.LAB 18907
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20210517_pre.xml EX-101.PRE 11874
7 EXTRACTED XBRL INSTANCE DOCUMENT d168523d8k_htm.xml XML 3514
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 21933967
SIC: 2834 Pharmaceutical Preparations